Literature DB >> 16007150

The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library.

Tomohiro Kawaguchi1, Shunsuke Kato, Kazunori Otsuka, Gou Watanabe, Toshihiro Kumabe, Teiji Tominaga, Takashi Yoshimoto, Chikashi Ishioka.   

Abstract

Tumor suppressor p53 forms a homo-tetramer through its COOH-terminal oligomerization domain and acts as a sequence-specific transcription factor. We have analysed the interrelation among the transcriptional activities, the structure and the cancer-related mutations in the oligomerization domain by using a comprehensive missense mutation library. Here, we examined the ability of 184 mutant p53s in the domain to form an oligomer by expressing these mutant p53s in yeast, and compared the data with the previous information. We showed that specific residues in the alpha-helix and the beta-strand of the oligomerization domain were critical for both oligomer formation and sequence-specific transactivation, and the activities were closely related. In particular, the alpha-helix was more sensitive to amino-acid substitutions than the beta-strand. We found identity in the interrelation between the two activities, that is, monomer mutants were transcriptionally inactive whereas dimer and tetramer mutants retained their transcriptional activities. In TP53 mutation databases, a small number of mutations have been reported in this domain. Surprisingly, most do not encode p53s defective in functional properties. These results indicate that, although oligomer formation is essential for p53 transactivation function, the inactivation of oligomer formation and therefore the inactivation of transactivation may not be essential for tumor suppression by p53 because they do not lead to oncogenic proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007150     DOI: 10.1038/sj.onc.1208839

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

1.  Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.

Authors:  Rui Kamada; Takao Nomura; Carl W Anderson; Kazuyasu Sakaguchi
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

2.  Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome.

Authors:  Nicholas W Fischer; Aaron Prodeus; James Tran; David Malkin; Jean Gariépy
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

3.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel.

Authors:  Abel González-Pérez; Nuria López-Bigas
Journal:  Am J Hum Genet       Date:  2011-03-31       Impact factor: 11.025

4.  Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.

Authors:  Gu Xiao; George K Annor; Kimberly Fung; Outi Keinänen; Brian M Zeglis; Jill Bargonetti
Journal:  Mol Pharm       Date:  2020-12-08       Impact factor: 4.939

5.  C-terminal region of human p53 attenuates buffalo p53 N-terminal-specific transactivation of p21 promoter by modulating tetramerization of the protein.

Authors:  Minu Singh; Tapas Mukhopadhyay
Journal:  Mol Cell Biochem       Date:  2017-11-16       Impact factor: 3.396

6.  NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity.

Authors:  Nasir Haider; Previn Dutt; Bert van de Kooij; Jason Ho; Luis Palomero; Miquel Angel Pujana; Michael Yaffe; Vuk Stambolic
Journal:  Oncogene       Date:  2020-06-19       Impact factor: 9.867

7.  Activation and control of p53 tetramerization in individual living cells.

Authors:  Giorgio Gaglia; Yinghua Guan; Jagesh V Shah; Galit Lahav
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-04       Impact factor: 11.205

8.  One-Dimensional Search Dynamics of Tumor Suppressor p53 Regulated by a Disordered C-Terminal Domain.

Authors:  Agato Murata; Yuji Itoh; Eriko Mano; Saori Kanbayashi; Chihiro Igarashi; Hiroto Takahashi; Satoshi Takahashi; Kiyoto Kamagata
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 4.033

9.  p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis.

Authors:  Nicholas W Fischer; Aaron Prodeus; David Malkin; Jean Gariépy
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

Review 10.  The Inherited p53 Mutation in the Brazilian Population.

Authors:  Maria Isabel Achatz; Gerard P Zambetti
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.